Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low at $7.57

Evotec SE (OTCMKTS:EVTCY)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $7.57 and last traded at $7.65, with a volume of 33841 shares traded. The stock had previously closed at $7.36.

Evotec Stock Performance

The firm has a market cap of $1.68 billion, a PE ratio of 12.44 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The company has a 50-day simple moving average of $7.33 and a two-hundred day simple moving average of $8.68.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.